文献速递结核与非结核分枝杆菌

通过检测胸腔积液中游离脱氧核糖核酸评估微滴式数字聚合酶链反应诊断结核性胸膜炎:一项多中心队列研究

Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study.
PubMed 文献 · Clin Microbiol Infect · 2024-05-27

这项多中心队列研究在中国6省9个中心连续纳入321例疑似结核性胸膜炎患者(≥5岁),最终281例数据可用,其中确诊105例、可能113例、非结核63例。cf-ddPCR在确诊组灵敏度90.5%,显著高于培养法57.1%、Xpert 46.7%、Ultra 69.5%和实时PCR 75.2%;在可能组灵敏度61.1%,仍显著高于Ultra 27.4%和实时PCR 38.9%。

要点

  • cf-ddPCR在确诊结核性胸膜炎组灵敏度90.5%,显著高于培养法、Xpert、Ultra和实时PCR。
  • 在培养和Xpert均阴性的可能结核性胸膜炎组,cf-ddPCR灵敏度61.1%,仍显著高于Ultra和实时PCR。
  • 作者认为cf-ddPCR性能优于培养法、Xpert、Ultra和实时PCR,可预期提高诊断准确性。

核心结论

  • cf-ddPCR的诊断性能优于培养法、Xpert、Ultra和实时PCR,作者认为采用该新检测可预期提高诊断准确性。

研究设计与样本

  • 多中心队列研究,2020年9月至2022年5月在中国6省9个研究中心连续纳入≥5岁疑似结核性胸膜炎且伴胸腔积液的患者。
  • 所有标本同时进行培养法、Xpert、Xpert MTB/RIF Ultra、实时PCR和cf-ddPCR检测。
  • 共纳入321例参与者,281例(87.5%)数据可用,按复合参考标准分为确诊结核性胸膜炎105例、可能结核性胸膜炎113例和非结核性胸膜炎63例。

主要发现

  • 确诊结核性胸膜炎组cf-ddPCR灵敏度90.5%(95/105,95%CI 82.8-95.1%),显著高于培养法57.1%(60/105,95%CI 47.1-66.6%,p<0.001)。
  • 确诊结核性胸膜炎组cf-ddPCR灵敏度显著高于Xpert 46.7%(49/105,95%CI 37.0-56.6%,p<0.001)、Ultra 69.5%(73/105,95%CI 59.7-77.9%,p<0.001)和实时PCR 75.2%(79/105,95%CI 65.7-82.9%,p<0.001)。
  • 在培养法和Xpert均阴性的可能结核性胸膜炎组,cf-ddPCR灵敏度61.1%(69/113,95%CI 51.4-70.0%),显著高于Ultra 27.4%(31/113,95%CI 19.7-36.8%,p<0.001)和实时PCR 38.9%(44/113,95%CI 30.0-48.6%,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tuberculous pleurisy is one of the most common types of extra-pulmonary tuberculosis, but the sensitivity of conventional mycobacterial culture (Culture) or Xpert MTB/RIF assay (Xpert) is not satisfying. This multicentre cohort study evaluated the accuracy of a new cell-free DNA droplet digital PCR assay (cf-ddPCR) for diagnosing tuberculous pleurisy. METHODS: Patients with suspected tuberculosis (≥5 years of age) with pleural effusion were consecutively recruited from nine research sites across six provinces in China between September 2020 to May 2022. Culture, Xpert, Xpert MTB/RIF Ultra assay (Ultra), real-time PCR, and cf-ddPCR were performed simultaneously for all specimens. RESULTS: A total of 321 participants were enrolled, and data from 281 (87.5%) participants were available, including 105 definite tuberculous pleurisy, 113 possible tuberculous pleurisy and 63 non-tuberculous pleurisy according to the composite reference standard. The sensitivity of cf-ddPCR was 90.5% (95/105, 95% CI, 82.8-95.1%) in the definite tuberculous pleurisy group, which was significantly higher than those of Culture (57.1%, 60/105, 95% CI, 47.1-66.6%, p < 0.001), Xpert (46.7%, 49/105, 95% CI, 37.0-56.6%, p < 0.001), Ultra (69.5%, 73/105, 95% CI, 59.7-77.9%, p < 0.001) and real-time PCR (75.2%, 79/105, 95% CI, 65.7-82.9%, p < 0.001). In possible tuberculous pleurisy, whose results of Culture and Xpert were both negative, the sensitivity of cf-ddPCR was 61.1% (69/113, 95% CI, 51.4-70.0%), which was still significantly higher than that of Ultra (27.4%, 31/113, 95% CI, 19.7-36.8%, p < 0.001) and real-time PCR (38.9%, 44/113, 95% CI, 30.0-48.6%, p < 0.001). DISCUSSION: The performance of cf-ddPCR is superior to Culture, Xpert, Ultra, and real-time PCR, indicating that improved diagnostic accuracy can be anticipated by incorporating this new assay.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Xu F, Du W, Li C, et al. Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study. Clin Microbiol Infect. 2024. PMID: 38810928. doi:10.1016/j.cmi.2024.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。